Refractal Overview

  • Founded
  • 2016

Founded
  • Status
  • Private

  • Employees
  • 8

Employees
  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $7.7M

  • Investors
  • 12

Refractal General Information

Description

Manufacturer of a scalable sensor system designed to detect viruses and proteins, with an acute focus on addressing the SARS-CoV-2 pandemic. The company has developed localized surface plasmon resonance (LSPR) biosensor technology, low-cost reader HW and its relating application, enabling physicians to precisely treat patients within time and end the global SARS-CoV-2 pandemic.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Other Devices and Supplies
Primary Office
  • 2261 Market Street
  • Suite 4216
  • San Francisco, CA 94114
  • United States
+1 (734) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Refractal Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 18-Sep-2020 $7.7M 00.000 000.00 Completed Generating Revenue
4. Grant 01-Jan-2018 00000 00000 Completed Generating Revenue
3. Accelerator/Incubator 22-Aug-2017 00000 00000 00.000 Completed Generating Revenue
2. Accelerator/Incubator 21-Jun-2016 Completed Startup
1. Grant 16-Apr-2016 $130K Completed Startup
To view Refractal’s complete valuation and funding history, request access »

Refractal Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 4 000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Seed 3 000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Seed 2 00,000 00.000000 00 00.00 00.00 00 00.00 0.00
Seed 1 148,522 $0.000100 8% $0.67 $0.67 1x $0.67 0.81%
Seed 5,921,156 $0.000100 8% $1.24 $1.24 1x $1.24 32.12%
To view Refractal’s complete cap table history, request access »

Refractal Executive Team (3)

Name Title Board Seat Contact Info
Walker McHugh Co-Founder, President, Chief Executive Officer & Board Member
Caroline Landau Co-Founder & Chief Operating Officer
Timothy Cornell Co-Founder & Chief Scientific Officer
To view Refractal’s complete executive team members history, request access »

Refractal Board Members (1)

Name Representing Role Since
Walker McHugh Refractal Co-Founder, President, Chief Executive Officer & Board Member 000 0000
To view Refractal’s complete board members history, request access »

Refractal Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Refractal Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Hillsven Venture Capital Minority 000 0000 000000 0
Houston Angel Network Angel Group Minority 000 0000 000000 0
Invest Detroit Ventures Corporate Venture Capital Minority 000 0000 000000 0
National Institutes of Health Government Minority 000 0000 000000 0
Paul Buchheit Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »